Tag: diabetes mellitus type 2

Neurology

Suboptimal Diet May Drive $50 Billion in Cardiometabolic Costs

Newsemia
Poor diet is associated with 18.2% of all costs related to treatment of ischemic heart disease, stroke, and type 2 diabetes in the US, new...
Neurology

ADA Advises Wider Use of Newer Glucose-Lowering Drugs

Newsemia
In the 2020 Standards of Care, the American Diabetes Association advises consideration of SGLT2 inhibitors and GLP-1 receptor agonists in patients with high CVD or...
Neurology

New ADA Update: Liraglutide for Youth and Technology Issues

Newsemia
Liraglutide for youth, dulaglutide cardiovascular outcomes data, and ‘time-in-range’ guidelines inform the latest Living Standards updates. Medscape Medical News Source link...
Neurology

'Double Whammy': Where do PCSK9 Inhibitors Fit for Diabetes/ACS?

Newsemia
Patients with diabetes as well as ACS and uncontrolled high cholesterol have a "double whammy" that makes them candidates for PCSK9 inhibitors to prevent CV...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World